基因工程抗体

通过基因工程可以大规模地制备能与人相容的单克隆抗体或其片段,用于诊断、治疗以及抗体结构与功能的研究。基因工程抗体的制备过程是通过PCR技术获得抗体或其片段的基因,再与适当的载体重组后引入不同的宿主系统,如哺乳动物细胞、昆虫细胞、大肠杆菌和植物中进行表达、装配。较详细地介绍了基因工程抗体的背景、现状和进展。     

转基因技术在植物抗体上的应用

通过基因工程技术在植物中表达或生产的抗体是近年来研究的热点。研究表明,不论是全抗体或小分子抗体,在植物中表达后都具有与抗原结合的活性,即具功能性,从而使植物抗体的研究备受人们的关注。该文介绍防龋抗体在转基因植物中的表达;高等植物叶绿体基因组的应用;植物病毒载体生产抗体和植物抗体的糖基化。     

抗肠炎沙门氏菌单链抗体制备及其特异性分析

目的:利用基因工程技术制备抗肠炎沙门氏菌的单链抗体.方法:从抗肠炎沙门氏菌单克隆抗体的杂交瘤细胞中纯化RNA,反转录后扩增出抗体的重链可变区(VH)和轻链可变区(VL)基因片段,采用重叠延伸的方法,用柔性多肽Linker接头(Gly4 Ser)3按VL-Linker-VH方式将VH基因和VL基因拼接成单链抗体基因片段后,连接到pGEX-4T-1载体上,进行重组转化.挑取阳性克隆,经IPTG诱导后,通过GST柱进行亲和层析,最后利用ELISA检测抗体的活性.结果:成功构建了表达抗肠炎沙门氏菌单链抗体的基因工程菌株,经SDS-PAGE和ELISA检测结果表明,诱导表达的单链抗体scFv分子量约为60 kDa,其能特异与肠炎沙门氏菌结合,但与副甲伤寒沙门氏菌、鸭沙门氏菌、鼠伤寒沙门氏菌有轻度交叉反应.结论:成功构建了抗肠炎沙门氏菌单链抗体的表达菌株,表达的单链抗体scFv可作为沙门氏菌的检测的候选抗体分子.     

菊花CmDFR与CmANS基因启动子序列克隆与瞬时表达分析

DFR和ANS是花青素合成途径下游两个关键的结构基因,其不仅决定花青素苷最终结构及其呈色,还在花器官中特异性表达,研究其启动子区域对花色改良的分子育种具有重要参考价值.利用接头染色体步移法( genome walking),从菊花的叶片基因组DNA中克隆到了2个DFR基因同源序列CmDFR的启动子片段,1个ANS基因同源序列CmANS的启动子片段.生物信息学软件分析结果显示,这3个启动子片段除了含有多个TATA-box、CAAT-box等基本的启动子元件,还含有很多与MYB转录因子相结合的元件,以及G-box等参与光响应的顺式作用元件.利用双酶切方法,将克隆到的启动子片段替换栽体pB1121上的35S启动子,将新构建的植物表达栽体转入农杆菌中,采用叶盘法侵染菊花叶片和花瓣进行瞬时表达研究.结果表明,这3个启动子片段均具有驱动下游报告基因表达的功能.因此,可以开发成菊花分子育种的有效基因构件.     

利用线性表达框高通量表达人源单克隆抗体

目的:建立不通过克隆步骤高通量表达来源于人单个B细胞的抗体轻、重链基因的方法。方法和结果:PCR扩增3个末端重叠的DNA片段,即1CMV启动子和编码抗体引导区序列的片段;2抗体Ig G1重链恒定区序列和牛生长激素(BGH)poly(A)信号序列,轻链Igκ恒定区序列和BGH poly(A)信号序列,轻链Igλ恒定区序列和BGH poly(A)信号序列;以及3抗体基因可变区序列V_H、V_κ或V_λ。3个片段通过重叠延伸PCR构建全长线性片段即线性表达框,将此来源于人单个B细胞的配对的抗体轻、重链线性表达框共转染293E细胞,72 h收集上清检测到表达的抗体。结论:构建的抗体基因线性表达框是无须克隆,快速高通量表达抗体基因进行筛选分析的策略。     

斑马鱼心脏标志基因TNC多克隆抗体的制备及表达研究

TNC是心脏发育的标志基因,但该基因在斑马鱼中的表达尚未研究。斑马鱼TNC基因基因的开放阅读框含有5132bp,编码1710个氨基酸,采用生物信息学结合PCR的方法获得了斑马鱼TNC基因的片段。将所得的PCR片段插入原核表达载体pGEX-4T-1中,并将重组质粒（pGEX-4T-1-TNC）转化大肠杆菌BL21;通过IPTG诱导表达GST—TNC融合蛋白,通过尿素洗涤沉淀蛋白并切胶回收纯化融合蛋白,免疫新西兰大白兔制备多克隆抗体。Western blot和免疫组化分析表明,制备的抗体具有良好的高效价性和特异性。利用该抗体进行斑马鱼胚胎抗体染色分析表明,TNC蛋白在心脏组织中特异表达。     

OC-I△D86（Oryzacystatin-I△D86）基因的原核表达及活性分析

根据OC-1△D86基因序列.设计合成了7条寡核苷酸片段.通过重叠延伸PCR技术合成了OC-I△D86基因,利用设计好的BamH1/Xho I酶切位点将OC-I△D86基因克隆到原核表达载体pet21b中,在1 mmol/L的IPTG诱导后5 h,OC-I△D86融合基因在大肠杆菌中得到表达,表达产物处于可溶状态,其表达量占总蛋白的11.4%,可溶性蛋白的16.4%:利用Ni-NTA系统纯化该蛋白并经PEG20000浓缩后.活性分析表明该蛋白酶抑制剂在体外表现出对木瓜蛋白酶明显的抑制作用,这为转OC-I△lD86基因的抗根结线虫植物基因工程抗体制备,以及进一步体内的抗根结线虫研究奠定了基础.     

OS-9基因的融合表达、纯化及多克隆抗体制备

OS 9基因广泛表达于人体多种组织 ,该基因的表达产物可能与肿瘤的发生相关 .为获得可溶性表达的OS 9蛋白 ,制备多克隆抗体 ,深入了解OS 9基因的功能 ,将OS 9基因片段克隆入组氨酸标签融合的表达载体pET2 8a中 ,IPTG诱导 ,利用金属螯合亲和层析 (MCAC)进行纯化 ,薄层扫描及Bradford法检测纯化蛋白的纯度与含量 .免疫家兔制备多克隆抗体 ,利用间接ELISA法检测抗体效价 ,Western印迹检测抗体特异性 .经表达形式分析证明 ,融合蛋白大部分可溶 .薄层扫描分析纯度可达 90 %以上 ,Bradford法检测蛋白浓度约 0 1mg ml.抗血清效价可达 1∶32 0 0以上 ,Western印迹检测证明抗体特异性良好 .经诱导表达及纯化制备出可溶的纯度较高的OS 9蛋白产物 ,并获得高效价特异性良好的多克隆抗体     

DNA条形码技术在植物中的研究现状

DNA条形码技术（DNA barcoding）是用短的DNA片段对物种进行识别和鉴定的分子生物学技术。在动物研究中该技术已经成功应用于利用线粒体细胞色素c氧化酶亚基I（COI）进行物种鉴定和发现隐种或新物种。相对于动物, COI基因在高等植物中进化速率较慢, 因此植物条形码研究以叶绿体基因组作为重点, 但目前还处于寻找合适的基因片段阶段。许多学者对此进行了积极的探索, 报道了多种植物条形码的候选片段或组合, 但还没有获得满足所有标准的特征位点片段。该文介绍了DNA条形码的标准、优点、工作流程及数据分析方法, 总结了DNA条形码在植物中的研究现状。     

DNA条形码技术在植物中的研究现状

DNA条形码技术(DNA barcoding)是用短的DNA片段对物种进行识别和鉴定的分子生物学技术。在动物研究中该技术已经成功应用于利用线粒体细胞色素c氧化酶亚基I(COI)进行物种鉴定和发现隐种或新物种。相对于动物, COI基因在高等植物中进化速率较慢, 因此植物条形码研究以叶绿体基因组作为重点, 但目前还处于寻找合适的基因片段阶段。许多学者对此进行了积极的探索, 报道了多种植物条形码的候选片段或组合, 但还没有获得满足所有标准的特征位点片段。该文介绍了DNA条形码的标准、优点、工作流程及数据分析方法, 总结了DNA条形码在植物中的研究现状。     

Antibody production in plants

Production of heterologous proteins in plants has become increasingly efficient due to recent advances in plant biotechnology. Heterologous proteins that have specifically attracted a great deal of attention are plant-produced monoclonal antibodies. A variety of applications for these so-called plantibodies have been explored since they were first expressed in tobacco seven years ago. Both full length antibodies and antibody fragments produced in transgenic plants offer many intriguing possibilities to plant molecular biologists and plant breeders. However, questions such as how cellular targeting influences the expression and accumulation of these proteins in plants still need to be answered before the technology can be used commercially, on a large-scale.     

Expression of recombinant antibody (single chain antibody fragment) in transgenic plant Nicotiana tabacum cv. Xanthi

Plants offer an alternative inexpensive and convenient technology for large scale production of recombinant proteins especially recombinant antibodies (plantibodies). In this paper, we describe the expression of a model single chain antibody fragment (B6scFv) in transgenic tobacco. Four different gene constructs of B6scFv with different target signals for expression in different compartments of a tobacco plant cell with and without endoplasmic reticulum (ER) retention signal were used. Agrobacterium mediated plant transformation of B6scFv gene was performed with tobacco leaf explants and the gene in regenerated plants was detected using histochemical GUS assay and PCR. The expression of B6scFv gene was detected by western blotting and the recombinant protein was purified from putative transgenic tobacco plants using metal affinity chromatography. The expression level of recombinant protein was determined by indirect enzyme-linked immunosorbent assay. The highest accumulation of protein was found up to 3.28 % of the total soluble protein (TSP) in plants expressing B6scFv 1003 targeted to the ER, and subsequently expression of 2.9 % of TSP in plants expressing B6scFv 1004 (with target to apoplast with ER retention signal). In contrast, lower expression of 0.78 and 0.58 % of TSP was found in plants expressing antibody fragment in cytosol and apoplast, without ER retention signal. The described method/system could be used in the future for diverse applications including expression of other recombinant molecules in plants for immunomodulation, obtaining pathogen resistance against plant pathogens, altering metabolic pathways and also for the expression of different antibodies of therapeutic and diagnostic uses.     

Influence of Growth Conditions and Developmental Stage on N-Glycan Heterogeneity of Transgenic Immunoglobulin G and Endogenous Proteins in Tobacco Leaves

Plants are regarded as a promising system for the production of heterologous proteins. However, little is known about the influence of plant development and growth conditions on N-linked glycosylation. To investigate this, transgenic tobacco (Nicotiana tabacum cv Samsun NN) plants expressing a mouse immunoglobulin G antibody (MGR48) were grown in climate rooms under four different climate conditions, i.e. at 15 degrees C and 25 degrees C and at either low or high light conditions. N-glycans on plantibodies and soluble endogenous proteins were analyzed with matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS). Antibodies isolated from young leaves have a relatively high amount of high- mannose glycans compared with antibodies from older leaves, which contain more terminal N-acetylglucosamine. Senescence was shown to affect the glycosylation profile of endogenous proteins. The relative amount of N-glycans without terminal N-acetylglucosamine increased with leaf age. Major differences were observed between glycan structures on endogenous proteins versus those on antibodies, probably to be attributed to their subcellular localization. The relatively high percentage of antibody N-glycan lacking both xylose and fucose is interesting.     

Standardization and validation of an alkaline phosphatase-linked immunoassay to quantify a plant-derived antibody directed against the hepatitis B virus surface antigen

Immunopurification is one of the most effective chromatography steps to purify the hepatitis B surface antigen, which have successfully been used as an active pharmaceutical ingredient of hepatitis B vaccines. Plant-derived antibodies could be an appropriated ligand for such purposes because plants are the most cost-effective production systems and have the additional advantage that plant viruses cannot infect humans. In this work, a polyclonal antibody alkaline phosphatase-linked immunoassay was standardized and validated to quantify a plant-derived antibody directed against the HBsAg. The validation of an immunoassay to quantify plantibodies is a relatively complex task due to the complexity of the plant extract, the low level of expression of this molecule, and the potential interferences of endogenous peroxidases contributed by plants. These results allow estimating the plant-derived antibody concentration up to 3.81 ng/mL with high specificity, precision, and repeatability. The working range of the standard curve was between 3.81 and 60 ng/mL, and the intra- and inter-variation coefficients were between 10% and 20% in a production process's sample dependent way. This enzyme-linked immunosorbent assay is considered valuable to improve the design of the purification process and also to obtain a better estimation of the antibody expression level and process's recovery.     

Detection of Rubisco and mycotoxins as potential contaminants of a plantibody against the hepatitis B surface antigen purified from tobacco

Antibodies have been one of the proteins widely expressed in tobacco plants for pharmaceutical purposes, which demand contaminant free preparations. Rubisco constitutes 40-60% of tobacco leaf soluble proteins; therefore it is the major potential protein contaminant of plantibodies, while mycotoxins are toxic compounds that could be introduced during the biomass production and post-harvest stages with important consequences to human health. The objective of this paper was to investigate whether Rubisco and mycotoxins are present in Plantibody HB-01 preparations used in the immunopurification of the hepatitis B surface antigen. Rubisco was purified from Nicotiana tabacum yielding 154 microg of protein per gram of leaves and purity over 95%. Among mouse monoclonal antibodies generated against this enzyme, the CBSS.Rub-2 was selected for its immunodetection. It recognizes a conserved sequential epitope of Rubisco large subunit with an affinity constant of 0.13 x 10(8)M(-1). Rubisco quantification limit was 1 microg spreading to the measurement of this contaminant less than 4% of plantibodies samples. Additionally, according to a Reverse Phase-HPLC used to measure the level of adventitiously introduced contaminants, it can be concluded that aflatoxins B1, B2, G1 and G2 were undetected in the purified Plantibody HB-01 samples.     

植物抗病毒病育种策略

为了得到抗病毒的寄主植物,植物育种学家进行了许多有益研究,形成了许多行之有效的抗病毒病育种策略。利用植物本身对病毒侵染所具有的一些免疫功能及其本身的一些抗性基因来获得抗性;利用来源于病毒自身基因的一些抗病性策略(PDR),如利用病毒外壳蛋白基因,病毒复制酶基因,病毒移动蛋白基因,病毒卫星RNA和反义RNA等,植物也可以获得抗性。近年来对由转录后RNA沉默引起的由RNA介导的病毒抗性策略(RMVR)也进行了深入地研究。除了PDR和RMVR以外,还有一些导致植物抗病毒的策略,包括利用美国商陆的病毒抗性蛋白(PAP),2',5’-寡腺苷酸合成酶,“植物抗体”以及病毒蛋白多肽来获得病毒抗性等。     

Trichoderma/pathogen/plant interaction in pre-harvest food security

Large losses before crop harvesting are caused by plant pathogens, such as viruses, bacteria, oomycetes, fungi, and nematodes. Among these, fungi are the major cause of losses in agriculture worldwide. Plant pathogens are still controlled through application of agrochemicals, causing human disease and impacting environmental and food security. Biological control provides a safe alternative for the control of fungal plant pathogens, because of the ability of biocontrol agents to establish in the ecosystem. Some Trichoderma spp. are considered potential agents in the control of fungal plant diseases. They can interact directly with roots, increasing plant growth, resistance to diseases, and tolerance to abiotic stress. Furthermore, Trichoderma can directly kill fungal plant pathogens by antibiosis, as well as via mycoparasitism strategies. In this review, we will discuss the interactions between Trichoderma/fungal pathogens/plants during the pre-harvest of crops. In addition, we will highlight how these interactions can influence crop production and food security. Finally, we will describe the future of crop production using antimicrobial peptides, plants carrying pathogen-derived resistance, and plantibodies.     

From sequence to antibody: genetic immunisation is suitable to generate antibodies against a rare plant membrane protein, the KAT 1 channel

Monoclonal antibodies against the K(+) channel KAT1 of Arabidopsis thaliana, a low abundance, plant plasma membrane protein, were generated by genetic immunisation to avoid the time and labour consuming purification of native or recombinant proteins and peptides usually necessary for conventional immunisation techniques. The resulting polyclonal and monoclonal antibody sera recognised a single protein band in a microsomal fraction of wild-type A. thaliana leaves and in membrane fractions of transgenic yeast cells and tobacco plants expressing the KAT1 protein. Therefore, genetic immunisation is suitable for generating monoclonal antibodies against plant proteins and particularly, against plant membrane proteins of low abundance.     

Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III

In this study, we show that introduction of human N-acetylglucosaminyltransferase (GnT)-III gene into tobacco plants leads to highly efficient synthesis of bisected N-glycans. Enzymatically released N-glycans from leaf glycoproteins of wild-type and transgenic GnT-III plants were profiled by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in native form. After labeling with 2-aminobenzamide, profiling was performed using normal-phase high-performance liquid chromatography with fluorescence detection, and glycans were structurally characterized by MALDI-TOF/TOF-MS and reverse-phase nano-liquid chromatography-MS/MS. These analyses revealed that most of the complex-type N-glycans in the plants expressing GnT-III were bisected and carried at least two terminal N-acetylglucosamine (GlcNAc) residues in contrast to wild-type plants, where a considerable proportion of N-glycans did not contain GlcNAc residues at the nonreducing end. Moreover, we have shown that the majority of N-glycans of an antibody produced in a plant expressing GnT-III is also bisected. This might improve the efficacy of therapeutic antibodies produced in this type of transgenic plant.     

N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants

Since plants are emerging as an important system for the expression of recombinant glycoproteins, especially those intended for therapeutic purposes, it is important to scrutinize to what extent glycans harbored by mammalian glycoproteins produced in transgenic plants differ from their natural counterpart. We report here the first detailed analysis of the glycosylation of a functional mammalian glycoprotein expressed in a transgenic plant. The structures of the N-linked glycans attached to the heavy chains of the monoclonal antibody Guy's 13 produced in transgenic tobacco plants (plantibody Guy's 13) were identified and compared to those found in the corresponding IgG1 of murine origin. Both N-glycosylation sites located on the heavy chain of the plantibody Guy's 13 are N-glycosylated as in mouse. However, the number of Guy's 13 glycoforms is higher in the plant than in the mammalian expression system. Despite the high structural diversity of the plantibody N-glycans, glycosylation appears to be sufficient for the production of a soluble and biologically active IgG in the plant system. In addition to high-mannose-type N-glycans, 60% of the oligosaccharides N-linked to the plantibody have beta(1, 2)-xylose and alpha(1, 3)-fucose residues linked to the core Man3GlcNAc2. These plant-specific oligosaccharide structures are not a limitation to the use of plantibody Guy's 13 for topical immunotherapy. However, their immunogenicity may raise concerns for systemic applications of plantibodies in human.